Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1

被引:10
作者
Campos, Melissa [1 ]
Albrecht, Lauren V. [1 ,2 ]
机构
[1] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Irvine, CA 92697 USA
关键词
glycolysis; spatiotemporal; phosphofructokinase-1; subcellular; condensate; glucosome; localization; compartmentalization; cancer; optogenetics; CELLULAR-DISTRIBUTION; GLYCOLYTIC-ENZYMES; MUSCLE; EXPRESSION; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; MICROTUBULES; ORGANIZATION; BINDING; GROWTH; ACTIN;
D O I
10.3390/cancers16010016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Glucose metabolism was the first metabolic pathway to be discovered and serves a central role across all life by generating energy. Cancer cells hijack glycolysis to promote growth and metastasis. Understanding the molecular basis of glycolytic rewiring in cancers could illuminate new treatment approaches.Abstract Glycolysis is the central metabolic pathway across all kingdoms of life. Intensive research efforts have been devoted to understanding the tightly orchestrated processes of converting glucose into energy in health and disease. Our review highlights the advances in knowledge of how metabolic and gene networks are integrated through the precise spatiotemporal compartmentalization of rate-limiting enzymes. We provide an overview of technically innovative approaches that have been applied to study phosphofructokinase-1 (PFK1), which represents the fate-determining step of oxidative glucose metabolism. Specifically, we discuss fast-acting chemical biology and optogenetic tools that have delineated new links between metabolite fluxes and transcriptional reprogramming, which operate together to enact tissue-specific processes. Finally, we discuss how recent paradigm-shifting insights into the fundamental basis of glycolytic regulatory control have shed light on the mechanisms of tumorigenesis and could provide insight into new therapeutic vulnerabilities in cancer.
引用
收藏
页数:14
相关论文
共 99 条
[1]   Hypoxia-Modified Cancer Cell Metabolism [J].
Al Tameemi, Wafaa ;
Dale, Tina P. ;
Al-Jumaily, Raked M. Kh ;
Forsyth, Nicholas R. .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
[2]   Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses [J].
Anastasiou, Dimitrios ;
Poulogiannis, George ;
Asara, John M. ;
Boxer, Matthew B. ;
Jiang, Jian-kang ;
Shen, Min ;
Bellinger, Gary ;
Sasaki, Atsuo T. ;
Locasale, Jason W. ;
Auld, Douglas S. ;
Thomas, Craig J. ;
Vander Heiden, Matthew G. ;
Cantley, Lewis C. .
SCIENCE, 2011, 334 (6060) :1278-1283
[3]  
Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI [10.1007/s10863-007-9080-3, 10.1007/S10863-007-9080-3]
[4]   Fructose 2,6-Bisphosphate in Cancer Cell Metabolism [J].
Bartrons, Ramon ;
Simon-Molas, Helga ;
Rodriguez-Garcia, Ana ;
Castano, Esther ;
Navarro-Sabate, Aurea ;
Manzano, Anna ;
Martinez-Outschoorn, Ubaldo E. .
FRONTIERS IN ONCOLOGY, 2018, 8
[5]   ACTIVATION AND INACTIVATION OF RAT-LIVER PHOSPHOFRUCTOKINASE BY PHOSPHORYLATION-DEPHOSPHORYLATION [J].
BRAND, IA ;
SOLING, HD .
FEBS LETTERS, 1975, 57 (02) :163-168
[6]   Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development [J].
Bulusu, Vinay ;
Prior, Nicole ;
Snaebjornsson, Marteinn T. ;
Kuehne, Andreas ;
Sonnen, Katharina F. ;
Kress, Jana ;
Stein, Frank ;
Schultz, Carsten ;
Sauer, Uwe ;
Aulehla, Alexander .
DEVELOPMENTAL CELL, 2017, 40 (04) :331-341
[7]   Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness [J].
Chen, Shengmiao ;
Wu, Yiran ;
Gao, Yang ;
Wu, Chenxu ;
Wang, Yuetong ;
Hou, Chun ;
Ren, Miao ;
Zhang, Shuyuan ;
Zhu, Qi ;
Zhang, Jiali ;
Yao, Yufeng ;
Huang, Mei ;
Qi, Yingchuan B. ;
Liu, Xue-Song ;
Horng, Tiffany ;
Wang, Haopeng ;
Ye, Dan ;
Zhu, Zhengjiang ;
Zhao, Suwen ;
Fan, Gaofeng .
CELL REPORTS, 2023, 42 (10)
[8]   Relocation of phosphofructokinases within epithelial cells is a novel event preceding breast cancer recurrence that accurately predicts patient outcomes [J].
Cheung, Richard A. ;
Kraft, Alexandra M. ;
Petty, Howard R. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 321 (04) :C654-C670
[9]   Targeting 6-Phosphofructo-2-Kinase ( PFKFB3) as a Therapeutic Strategy against Cancer [J].
Clem, Brian F. ;
O'Neal, Julie ;
Tapolsky, Gilles ;
Clem, Amy L. ;
Imbert-Fernandez, Yoannis ;
Kerr, Daniel A., II ;
Klarer, Alden C. ;
Redman, Rebecca ;
Miller, Donald M. ;
Trent, John O. ;
Telang, Sucheta ;
Chesney, Jason .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) :1461-1470
[10]   Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma [J].
Coelho, Raquel G. ;
Calaa, Isadora C. ;
Celestrini, Deborah M. ;
Correia-Carneiro, Ana Helena P. ;
Costa, Mauricio M. ;
Zancan, Patricia ;
Sola-Penna, Mauro .
ONCOTARGET, 2015, 6 (30) :29375-29387